Hypertension Trial, Recruiting NCT05522075 Sponsor: The University of Texas at Arlington Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05522075
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women between 50 and 64 years of age who either do not drink alcohol, drink at moderate levels, or occasionally binge drink.
  • Women who have gone through menopause, meaning their periods stopped at least one year ago.
  • People who can speak and understand English.

Who may not be able to join:

  • People with a history of diabetes, heart disease, liver disease, or kidney disease.
  • People who currently smoke or have a history of smoking, or who currently use or have a history of using illegal drugs.
  • People whose blood pressure is 160/100 or higher.
  • People with obesity (a BMI of 35 or above) or high cholesterol levels (total cholesterol above 230 mg/dl and/or LDL cholesterol above 160 mg/dl).
  • People who have had an active infection in the past 2 months.
  • People with a history of seizures, cancer, or inflammatory conditions such as gout or rheumatoid arthritis.
  • People whose body weight has changed by more than 5% in the past 6 months.
  • People who regularly do structured aerobic exercise, meaning 30 minutes or more of aerobic activity at least 3 times per week.
  • People who are currently using hormone replacement therapy, including estrogen, progesterone, or testosterone.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chueh-Lung Hwang, PhD, University of Texas at Arlington

Phone: 8172729722

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas at Arlington
Registry
ClinicalTrials.gov
Start date
21 November 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of high-intensity interval training

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov